Literature DB >> 18636172

Evaluation of PRL-3 expression, and its correlation with angiogenesis and invasion in hepatocellular carcinoma.

Wen-Bo Zhao1, Ying Li, Xin Liu, Ling-Yan Zhang, Xin Wang.   

Abstract

Protein phosphatase of regenerating liver 3 (PRL-3) is a metastasis-associated phosphatase. Studies have shown that its overexpression increases cell motility and invasiveness. In this study, we aimed to investigate the expression of PRL-3 in hepatocellular carcinoma (HCC) tumor tissues and determine its correlations with matrix metalloproteinases (MMP-2, MMP-9) and E-cadherin in HCC. Paired cancerous and non-cancerous tissues were freshly collected from 42 primary HCC patients. PRL-3 expression at both mRNA and protein level was evaluated by real-time PCR, Western blot analysis and immunohistochemistry. The microvessel density (MVD) in HCC was detected with immunohistochemistry. The mRNA expression of MMP-2, MMP-9 and E-cadherin was analyzed by real-time PCR in search of correlations with PRL-3. We found that PRL-3 was significantly up-regulated in the HCC tumor tissues compared with corresponding noncancerous liver tissues (0.664+/-0.053 vs. 0.024+/-0.003, P<0.001). The mRNA level of PRL-3 in tissues was correlated with serum alpha-fetoprotein level, vascular invasion and metastasis (P<0.001). PRL-3 expression was closely related to MVD. Furthermore, we found a significant correlation between PRL-3 mRNA expression and MMP-2, MMP-9 and E-cadherin. Our results demonstrated that PRL-3 is up-regulated in HCC. It is strongly suggested that PRL-3 plays a key role in the angiogenesis and invasion of HCC. MMP-2, MMP-9 and E-cadherin might be involved in PRL-3 functions in HCC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18636172

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  23 in total

Review 1.  Targeting protein tyrosine phosphatases for anticancer drug discovery.

Authors:  Latanya M Scott; Harshani R Lawrence; Saïd M Sebti; Nicholas J Lawrence; Jie Wu
Journal:  Curr Pharm Des       Date:  2010-06       Impact factor: 3.116

2.  Tissue-specific alterations of PRL-1 and PRL-2 expression in cancer.

Authors:  Carmen M Dumaual; George E Sandusky; Han Weng Soo; Sean R Werner; Pamela L Crowell; Stephen K Randall
Journal:  Am J Transl Res       Date:  2012-01-05       Impact factor: 4.060

3.  Prognostic and metastatic value of phosphatase of regenerating liver-3 in invasive breast cancer.

Authors:  Ru-Tian Hao; Xiao-Hua Zhang; Yi-Fei Pan; Hai-Guang Liu; You-Qun Xiang; Li Wan; Xiu-Ling Wu
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-06       Impact factor: 4.553

Review 4.  Inside the human cancer tyrosine phosphatome.

Authors:  Sofi G Julien; Nadia Dubé; Serge Hardy; Michel L Tremblay
Journal:  Nat Rev Cancer       Date:  2011-01       Impact factor: 60.716

5.  Increased expression of PRL-1 protein correlates with shortened patient survival in human hepatocellular carcinoma.

Authors:  J-W Lu; J-G Chang; K-T Yeh; R-M Chen; J J P Tsai; W-W Su; R-M Hu
Journal:  Clin Transl Oncol       Date:  2012-04       Impact factor: 3.405

Review 6.  Phosphatase of regenerating liver: a novel target for cancer therapy.

Authors:  Amanda M Campbell; Zhong-Yin Zhang
Journal:  Expert Opin Ther Targets       Date:  2014-03-01       Impact factor: 6.902

Review 7.  Biomarkers for predicting future metastasis of human gastrointestinal tumors.

Authors:  Lui Ng; Ronnie Tung Ping Poon; Roberta Pang
Journal:  Cell Mol Life Sci       Date:  2013-01-31       Impact factor: 9.261

8.  Upregulation of protein tyrosine phosphatase type IVA member 3 (PTP4A3/PRL-3) is associated with tumor differentiation and a poor prognosis in human hepatocellular carcinoma.

Authors:  Abudureheman Mayinuer; Mahmut Yasen; Kaoru Mogushi; Gulanbar Obulhasim; Maimaiti Xieraili; Arihiro Aihara; Shinji Tanaka; Hiroshi Mizushima; Hiroshi Tanaka; Shigeki Arii
Journal:  Ann Surg Oncol       Date:  2012-10-13       Impact factor: 5.344

9.  Targeted deletion of the metastasis-associated phosphatase Ptp4a3 (PRL-3) suppresses murine colon cancer.

Authors:  Mark W Zimmerman; Gregg E Homanics; John S Lazo
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

10.  Drosophila PRL-1 is a growth inhibitor that counteracts the function of the Src oncogene.

Authors:  Krystle T Pagarigan; Bryce W Bunn; Jake Goodchild; Travis K Rahe; Julie F Weis; Leslie J Saucedo
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.